Can CBD protect newborn nerve cells after injury? ↗
Rat study finds CBD enhances motor neuron survival by 54% after neonatal nerve injury, with sustained benefits at 8 weeks through CB1 receptor-dependent mechanisms.
Browse more cannabis research, findings, methods, and limitations.
Rat study finds CBD enhances motor neuron survival by 54% after neonatal nerve injury, with sustained benefits at 8 weeks through CB1 receptor-dependent mechanisms.
Australian policy analysis finds zero-tolerance THC driving laws harm medicinal cannabis patients without evidence of greater road risk compared to other impairing prescription drugs.
Cannabis activates the same dopamine reward pathway as all drugs of abuse. The endocannabinoid system's role in modulating these signals may offer new targets for treating addiction broadly.
Prospective study of 181 medical marijuana patients finds improved quality of life, pain, and anxiety over 6 weeks, but a decline in self-care measures.
Study of 730 binge-drinking young adults finds daily cannabis use linked to impulsive reward choice and hyperactive ADHD symptoms, with no effects from occasional use.
Rat study finds prenatal cannabinoid exposure paradoxically enhances mitochondrial function and promotes neuronal survival in offspring cerebellum, unlike harmful effects seen in other brain regions.
Mouse autism model shows medical cannabis reduces repetitive behavior by 70% and anxiety, with THC appearing more important than CBD for core symptom improvement.
Study of 247 first-episode psychosis patients finds cannabis users had less social withdrawal but more severe delusions, with no cognitive differences.
Meta-analysis of 7 studies (106 patients) finds topical capsaicin provides symptom relief for cannabinoid hyperemesis syndrome, with mean resolution time around 5.4 hours.
THC promoted mineralization and bone-like tissue formation in human dental pulp cells through CB1/CB2 receptors — an unexpected finding with potential for dental regeneration research.
Large EU-GEI study finds genetic schizophrenia risk and daily cannabis use independently contribute to positive psychotic symptoms in both patients and healthy controls.
Large EU-GEI study finds daily high-potency cannabis use associated with the most severe positive psychotic symptoms in a dose-response pattern, while cannabis use was linked to fewer negative symptoms.
Real-world study of 279 patients finds CBD-rich treatment significantly improves pain, anxiety, and depression at 3 months, but only in those with moderate-to-severe symptoms.
Systematic review of 28 studies finds packaging warnings, roadside testing, and motivational interviewing most effective for preventing drugged driving, while legal sanctions show little impact.
Ecological analysis finds US states with higher cannabis use and legal cannabis have higher pediatric leukemia rates, though the study design cannot prove individual-level causation.
Rat study finds prenatal alcohol and THC have opposing effects on hippocampal inhibitory neurons, with sex-specific effects and complex interactions when both are present.
Systematic review finds benzodiazepines, capsaicin, and haloperidol most effective for pediatric CHS, while traditional antiemetics frequently fail.
Study of 307 inpatients finds cannabis-induced psychosis differs from schizophrenia with fewer negative symptoms and more mania, with cannabis use linked to nearly a decade earlier first hospitalization.
Prospective study finds cannabis-using psychosis patients have higher dissociation and worsening functioning over 8 months, while non-users improve.
Study of 62 FEP patients finds cannabis use and treatment delay independently contribute to dissociative symptoms, though cannabis does not extend the untreated period itself.
Survey of 1,000 MS patients finds 30% currently use cannabis, with most using multiple routes and perceiving benefit, particularly among younger, lower-income, and more disabled patients.
Small crossover study finds specific EEG changes during cannabis intoxication, including decreased theta power and altered brain connectivity, suggesting potential for objective intoxication detection.
PNAS study links maternal cannabis use to suppressed placental immune genes, elevated cortisol, and increased anxiety and hyperactivity in children aged 3-6.
Survey of 157 Florida medical marijuana patients finds anxiety and pain are top uses, with 65% reducing or stopping other medications.
Study of 2,315 OUD patients finds overall cannabis use doesn't affect treatment outcomes, but daily cannabis use is associated with 39% lower odds of continued opioid use.
ABCD Study data from 11,875 children finds those in legal-cannabis states know more about marijuana but not other drugs, with no link between cannabis knowledge and behavioral problems.
Canadian national data shows cannabis use rose from 14% to 20% after legalization, with female rates matching male for the first time and legal purchasing increasing.
Triple-blind RCT finds haloperidol superior to ondansetron for CHS, with better symptom relief, fewer rescue medications, and 2.5-hour shorter ED stays.
Animal study finds adolescent female rats metabolize vaped THC differently than males, with higher active metabolite levels and greater behavioral sensitivity at lower doses.
Prospective study of 28 MS patients finds low-dose cannabis oils (4 mg THC, 7 mg CBD) significantly reduce pain, spasticity, and sleep problems without impairing function.
Rat study finds prenatal THC creates a latent dopamine dysfunction in offspring that emerges as psychotic-like behavior only when triggered by stress or drug challenge.
Double-blind crossover study in 18 cannabis users finds CBD significantly reduces THC's psychotic-like effects when co-administered as a full-spectrum extract.
Survey of 116 Florida medical marijuana physicians found wide practice variation, with only half providing specific THC:CBD ratio recommendations and many relying on anecdotal information alongside research.
National survey of 128,205 adults found 4.5% drove under the influence of cannabis, with rates climbing sharply among daily users (57% predicted probability) and those with cannabis use disorder (63.8%).
A 48-year-old man with long-term tobacco and cannabis smoking developed vanishing lung syndrome, a rare form of severe emphysema, highlighting potential additive respiratory risks from dual use.
Survey of 3,249 MS patients found 20% currently use cannabis for symptoms like spasticity (80%), pain (69%), and sleep (61%), while many non-users cited insufficient data on safety and efficacy.
Female rats showed biphasic THC anxiety responses that males didn't — anxiolytic at low doses, anxiogenic at high. CBD blocked the anxiety and enhanced the calm.
Multi-national study found first-episode psychosis patients reported more psychotic-like experiences during cannabis intoxication than controls, with sensitivity increasing at higher use levels, while euphoric experiences did not differ.
Study of 91 participants found that psychosis patients without cannabis history had worse smooth pursuit eye movements than those with cannabis history, suggesting less severe neurobiological impairment in cannabis-associated psychosis.
Study found patients with cannabinoid hyperemesis syndrome consumed more healthcare resources than non-users, driven by repeated evaluations before correct diagnosis, though cost differences were not consistently statistically significant.
Survey of 382 NYC families found 31% reported marijuana smoke entering their homes while with their children, with public housing residents 3.45 times more likely to be exposed.
Study of 53 young children in NYC found 20.8% had detectable marijuana metabolites in their urine, with rates nearly tripling in housing where smoking was allowed.
Study of 171 young regular cannabis users found sex-specific cognitive effects: males had poorer visual memory while females showed worse attention and executive function, with effect sizes in the medium-to-large range.
Study of 1,544 twins found that while cannabis use was associated with higher psychoticism scores, within-twin-pair comparisons showed no causal effect, suggesting shared genetics explain the link.
Study of 98 first-episode schizophrenia patients found cannabis users responded similarly to antipsychotic treatment over 24 months, but more frequent use predicted higher relapse risk.
Study of 1,276 participants found medical cannabis users reported better quality of life, less pain and anxiety, and fewer ER visits, with longitudinal data suggesting cannabis use may contribute to the differences.
Study found that cannabis-related DNA methylation changes in sperm, concentrated at developmental genes, were significantly diminished after 77 days of abstinence, suggesting reversibility.
A 25-year-old with Tourette syndrome saw over 90% tic reduction using nabiximols spray as needed, after standard medication failed.
Survey of 2,084 adults found that driving-while-high behavior is driven by a system of beliefs including attitudes, social norms, and perceived control, with intention being a stronger predictor than willingness alone.
Systematic review of 18 fMRI studies found regular cannabis users show consistently heightened brain activity in reward, executive control, and memory regions when exposed to cannabis cues, with preliminary links to craving.